Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer
Q Liu, Q Luo, A Halim, G Song - Cancer letters, 2017 - Elsevier
One of the most important metabolic hallmarks of cancer cells is deregulation of lipid
metabolism. In addition, enhancing de novo fatty acid (FA) synthesis, increasing lipid uptake …
metabolism. In addition, enhancing de novo fatty acid (FA) synthesis, increasing lipid uptake …
Lipid droplets: a key cellular organelle associated with cancer cell survival under normoxia and hypoxia
S Koizume, Y Miyagi - International journal of molecular sciences, 2016 - mdpi.com
The Warburg effect describes the phenomenon by which cancer cells obtain energy from
glycolysis even under normoxic (O2-sufficient) conditions. Tumor tissues are generally …
glycolysis even under normoxic (O2-sufficient) conditions. Tumor tissues are generally …
Programmed cell removal: a new obstacle in the road to developing cancer
MP Chao, R Majeti, IL Weissman - Nature Reviews Cancer, 2012 - nature.com
The development of cancer involves mechanisms by which aberrant cells overcome normal
regulatory pathways that limit their numbers and their migration. The evasion of programmed …
regulatory pathways that limit their numbers and their migration. The evasion of programmed …
[HTML][HTML] LDL receptor–related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system
SL Gonias, WM Campana - The American journal of pathology, 2014 - Elsevier
Low-density lipoprotein receptor–related protein-1 (LRP1) is an endocytic receptor for
numerous proteins that are both structurally and functionally diverse. In some cell types …
numerous proteins that are both structurally and functionally diverse. In some cell types …
High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study
Objective—Patients with cancer are at an increased risk for venous thromboembolism (VTE).
Clotting factor VIII activity (FVIII) has been established as risk factor of primary and recurrent …
Clotting factor VIII activity (FVIII) has been established as risk factor of primary and recurrent …
Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages
M Gorovoy, A Gaultier, WM Campana… - Journal of leukocyte …, 2010 - academic.oup.com
The shed form of LRP1/CD91, which is generated at increased levels in inflammation,
regulates cell-signaling and cytokine expression by macrophages. LRP1 is a type-1 …
regulates cell-signaling and cytokine expression by macrophages. LRP1 is a type-1 …
A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion
U Gopal, JE Bohonowych, C Lema-Tome, A Liu… - PloS one, 2011 - journals.plos.org
Background Extracellular Hsp90 protein (eHsp90) potentiates cancer cell motility and
invasion through a poorly understood mechanism involving ligand mediated function with its …
invasion through a poorly understood mechanism involving ligand mediated function with its …
The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1–mediated MMP-9 expression
B Fayard, F Bianchi, J Dey, E Moreno, S Djaffer… - Cancer research, 2009 - AACR
Through their ability to degrade the extracellular matrix, proteases mediate cancer cell
invasion and metastasis. Paradoxically, some serine protease inhibitors (serpins) are often …
invasion and metastasis. Paradoxically, some serine protease inhibitors (serpins) are often …
Fatty acids-from energy substrates to key regulators of cell survival, proliferation and effector function
Recent advances in immunology and cancer research show that fatty acids, their
metabolism and their sensing have a crucial role in the biology of many different cell types …
metabolism and their sensing have a crucial role in the biology of many different cell types …
[HTML][HTML] BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells
Target-specific treatment modalities are currently not available for triple-negative breast
cancer (TNBC), and acquired chemotherapy resistance is a primary obstacle for the …
cancer (TNBC), and acquired chemotherapy resistance is a primary obstacle for the …